Repositori Publikasi Penelitian Universitas Syiah Kuala

1. Hypertension 2018 : The Never Ending Battle Againts Hypertension and Its Complica Tions. http://www.inash.or.id/2018
2. Shifting Paradigms in Cardiovascular Disease International and regional Perspectives. https://www.gevme.com/cardioconnect-20182018
3. Low Cardiac Output Management in ICCU. http://www.asmiha.org/registration.html2018
4. Heart Failure, Burden, Evidence and Therapy. .2018
5. Paradigma Shift T2DM Management : Beyond Glycemic Control. .2018
6. Annual Scientific Meeting of Indonesian Heart Association. .2018
7. Annual Scientific Meeting of Indonesian Heart Association. .2018
8. The Reduction of Vasavasorum ANgiogenesis Through Lipoprotein Associated Phospolipase A2 Inhibition During Early Phase of Atherosclerosis. 2017
9. Association between Four Types of Single-Neucleotide Polymorphisms (SNPs) in PLA2G7 Gene and Clinocal Atherosclerosis . 2017
10. Certificate of Attendance Electrocardiography Course : From Basic-To Emergency. 2017
11. From Preventive to Curative Approach . 2017
12. European Accreditation Council for Continuing Medical education. 2017
13. 8th Asian PAD Workshop. 2017
14. Pelatihan sistem e-farmasi untuk tenaga medis di RSUD dr. Zainoel Abidin. http://rsudza.acehprov.go.id/2017
15. Multidisciplinary Approach to Cardiovascular Disease in All Levels of Care. http://www.asmiha.org/registration.html2017
16. Comprehensive on Management of Acute Coronary Syndrome. .2017
17. Seminar dan Diseminasi Hasil Penelitian dan pengabdian kepada Masyarakat Tahun 2017. http://lppm.unsyiah.ac.id/2017
18. Emergency and Intensive Care in Cardiovascular Disease. .2017
19. Emergency and Intensive Care in Cardiovascular Disease. .2017
20. How to Use Non-Invasive vascular Diagnostic. .2017
21. Workshop on Nuclear Cardiology and cardiovascular Imaging : Cardiac Magnetic Resonance. .2017
22. Multidisciplinary Approach to Cardiovascular Disease in All Levels of Care. .2017
23. From Preventive to Curative Approach. .2017
24. Lp-PLA2 in Development and Progression af Atherosclerosis: The Newest Original Finding. 2016
25. Effective Strategies for Blood Pressure Control and CVD Management. 2016
26. Asean Federation of Cariology Congress . 2016
27. European Accreditation Council for Continuing Medical education. 2016
28. From Emergency to Daily Practice in Cardiology. 2015
29. From Emergency to Daily Practice in Cardiology. 2015
30. Workshop Acute Coronary Syndrome. 2015
31. From Emergency to Daily Practice in Cardiology. 2015
32. 11 th Asia Pacific Congress of Hypertension in Conjunction with 9th Scientific Meeting of The Indonesian Society of Hypertension. 2015
33. The European Board for Accreditation in Cardiology (EBAC) has granted. 2015
34. Good Doctor For The Great Family. 2014
35. Join Meeting ESH-ISH Hypertension Athens 2014. 2014
36. Methods for Evaluating Medical Tests& Biomarkers of inflammation an immunology. 2014
37. International Conference on Advance Molecular Bioscience and Biomedical Engineering. 2014
38. Managing Cardiovascular risk factor to prenet the fatal end of cardiovascular cvontinuum. 2014
39. World Congrees of Cardiology 2014. 2014

1. The Predictors of No Reflow Phenomenon After Percutaneous Coronary Intervention in Patiens with ST Elevation Myocardial Infarction: A Meta - Analysis. https://ac.els-cdn.com/S0019483217308787/1-s2.0-S0019483217308787-main.pdf?_tid=spdf-46553d50-ad7f-4626-ac38-17f7d044db67&acdnat=1519792682_d641c262d49df856ee63405f86051472 2018
2. Inhibition Of Adhesion Moleculer Expression In Early Progression Of Atherosclerosis In Dyslipidemia Model On Sprague Dawley Rats By Darapladip. http://scialert.net/qredirect.php?doi=ijp.0000.87827.87827&linkid=pdf2018
3. Darapladip Inhibits Atherosclerosis Development In Type 2 Diabetes Mellitus Sprague-Dawley Rat Model. https://diabeteswellness.com/research/darapladip-inhibits-atherosclerosis-development-in-type-2-diabetes-mellitus-sprague-dawley-rat-model/2018
4. Porphyromonas gingivalis vesicles reduce MDA-LDL Level and Aortic Wall Thickness in high Fat diet Induced Atherosclerosis Rats. https://www.sciencedirect.com/science/article/pii/S18729312183003222018
5. Angiotensin-converting enzyme (ACE) I/D and brandykinin B2 recoptor T/C genes polymorphism in patients with ACE inhibitor-related cough. https://www.researchgate.net/publication/326013652_Angiotensin-converting_enzyme_ACE_ID_and_bradykinin_B2_receptor_TC_genes_polymorphism_in_patients_with_ACE_inhibitors-related_cough2018
6. The inhibitory effects of polysaccharide peptides (PsP) of Ganoderma lucidum against atherosclerosis in rats with dyslipidemia. http://web.a.ebscohost.com/abstract?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=18261868&AN=123881148&h=76TxoWcm1ZtKyiwJ1IL1ty%2b9%2byf7dQgeipb5Y%2bQUlckaTHr8meYcMNI6xybOK0CJnw4GO3gWjRFDQaAUn7PntQ%3d%3d&crl=c&resultNs=AdminWebAuth&resultLoc2017
7. Lowering Inflammation Level by Lp-PLA2 Inhibitor (Darapladib) in Early Atherosclerosis Developmet: in vivo Rat Type 2 Diabetes Mellitus Model. 2017
8. Darapladib Inhibit Adhesion Molecule Expression in Aorta at Early Stages of Atherosclerosis using Sprague-Dawley Type 2 Diabetes Mellitus Model. 2017
9. Elaborate evaluation of serum and tissue oxidized LDL level with darapladib therapy:A feasible diagnostic marker for early atherogenesis. http://www.sciencedirect.com/science/article/pii/S22211691163009832017
10. The effect of Darapladib as a Lippoprotein-associated Phospholipase A2 Inhibitor to Interleukin- 1ß and Interleukin-6 on Diabetes Mellitus Sprague-Dawley rat model: a New Therapeutic Target of diabetes Mellitus to Decrease Cardiovascular Risk. http://jprsolutions.info/files/final-file-5a23d76fb08f64.41849101.pdf2017
11. Lp-Pla2 Selective Inhibitor (Darapladib) Effect in Lowering Insulin Resistance and Aortic Tissue Inflammation at Type 2 Diabetes Mellitus. www.japsonline.com/admin/php/uploads/2508_pdf.pdf2017
12. Association between Four Types of Single-Nucleotide Polymorphin in PLA2G7 gene and Clinical Atherosclerosis: a meta-analysis. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768870/2017
13. Decresement Of Lysophosphatidylcholine Level,Nuclear Factor Kappa B Expression,Intima - Media Thickness and Improvement Of Insulin Resistance By Darapladib Treatment : In Vivo Studies Of Type 2 Diabetes Mellitus Sprague Dawley Rat Model. https://innovareacademics.in/journals/index.php/ajpcr/article/ viewFile/19022/133302017
14. Ox-LDL, Lysophospatidy Choline Platelet Activating Factor, IL-6 Expression Level and Foam Cell Number with Darappabdib Treatment in Early Development of Atherosclerosis : in Vivo Studi for Type 2 Diabetes Mellitus Model. 2016
15. Atherogenesis inhibition by darapladib administration in dyslipidemia model Sprague-Dawley rats. https://www.ejmanager.com/mnstemps/28/28-1443503718.pdf2016
16. Inhibition of Oxidative Streaa in Hypercolesterolemic Rats by Soy Milk. 2016
17. Evaluation subchronic toxic effect of polysaccharide peptide on lipid and hematologic profile in Rattus norvegicus strain Wistar. https://www.banglajol.info/index.php/BJMS/article/view/301962016
18. The Effect of Darapladip on Lipid Profile, Insulin, Ox-LDL Serum Level and PVAT Thickness At ATherogenesis Development in Dm Tipe 2 Rats Model. http://sphinxsai.com/2016/ph_vol9_no2/1/(01-08)V9N2PT.pdf2016
19. Reduction of histopathological images through a decrease in H2O2 Level in diabetic rats with polysaccharide peptides. http://www.sciencedirect.com/science/article/pii/S221402471400135X2015
20. The reduction of aorta histopathological images through inhibition of reactive oxygen species formation in hypercholesterolemia rattus norvegicus treated with polysaccharide peptide of Ganoderma lucidum. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475661/2015
21. Vasa Vasorum Angiogenesis through Increased Level of H2O2, HIF-I?, NF-kB and INOS: In Vivo Study of Atherosclerosis. www.jomb.org/index.php?m=content&c=index&a=show&catid=48&id...2015
22. Modulation of Paraoxonase Activity (PON)-1 by Xanthone in Sub Chronic Exposure of Orgnophosphate : ANtioxidant in Dichorvos Intoxicity. https://link.springer.com/article/10.1007/s13530-015-0232-22015
23. Anti Imflammation and Anti Oxidant Effect of Active Agent Polysaccharide Peptide (Ganoderma Lucidum) in Preventing Atherosclerotic Diseases. http://biomedpharmajournal.org/vol8no1/anti-inflammation-and-anti-oxidant-effect-of-active-agent-polysaccharide-peptide-ganoderma-lucidum-in-preventing-atherosclerotic-diseases-2/2015
24. Effects of subchronic exposure of PSP (Ganoderma lucidum on renal function and histopathology feature in Rattus novergicus Wistar strain. http://slhlabs.com/imagesrc/jurnal/Toxicity-study/Effects-of-subchronic-exposure-of-PSP-Ganoderma-lucidum-on-renal-function.pdf2015
25. Study of the inhibition effect of ethanolic extract of mangosteen pericarp on atherogenesis in hypercholesterolemic rat. http://www.sciencedirect.com/science/article/pii/S22221808156094092015
26. Polysaccharide Peptide : A promising Anti Inflammation and anti Oxidant in Atherosclerosis. 2015
27. Subchronic Toxicity of Ganoderma Lucidum Polysaccharide Peptide (PsP0 to Liver Physiology and Histopathologylmaging of Liver on Rattus Norvegicus Strain Wistar Rats. http://biomedpharmajournal.org/vol7no2/subchronic-toxicity-of-ganoderma-lucidum-polysaccharide-peptide-psp-to-liver-physiology-and-histopathologyimaging-of-liver-on-rattus-norvegicus-strain-wistar-rats/2014
28. Level of Circulating Endothelial Cells and Expressiion of Nuclear Factor Kappa Beta of Human's Peripheral Blood Mononuclear Cells in Subjects with Certain Conditions. http://actamedindones.org/index.php/ijim/article/view/612014
29. Pengaruh Berbagi Durasi Pemberian Diet Tinggi Lemak Terhadap Profil Lipid Tikus Putih (Rattus Novergicus Starin Wistar) Jantan. Http:/www.Jurnal.unsyiah.ac.id./JKS/article/view/3282/3089.2013
30. Pengaruh Pemberian Pentoksifilin Terhadap Perubahan Kadar Tumor Nekrosis Faktor Alfa Pada Cedera Reperfusi - Iskemik Tungkai Akut. Web. Http:/www.Jurnal.unsyiah.ac.id./JKS/article/view/3505/3258.2012

Data Publikasi Paten Belum Ada!!